Imfinzi

Indicated For

bladder cancer, lung cancer

About This Medication

# Imfinzi Patient Guide: How to Get Imfinzi at Low or No Cost Imfinzi (durvalumab) is a prescription immunotherapy medication used to treat certain types of bladder and lung cancer by helping the immune system fight cancer cells more effectively.[1] This guide explains how to access patient assistance through programs like Simplefill, which connects eligible patients to help covering the high costs of Imfinzi, administered as an intravenous infusion by a healthcare professional over 60 minutes.[1] ## About Imfinzi **Imfinzi** is a monoclonal antibody, a type of checkpoint inhibitor. Cancer cells often hide from the immune system using a protein called PDL-1 (programmed cell death ligand 1), which acts like a shield. Imfinzi binds to PDL-1, blocking it and making cancer cells "visible" to T cells—the immune system's attack cells. This helps destroy cancer cells while aiming to spare healthy ones, potentially increasing progression-free survival for patients with specific bladder or lung cancers.[1] Treatment schedules vary by cancer type, but infusions occur under medical supervision. Imfinzi is not a cure but part of regimens to slow cancer spread and extend life. Always consult your doctor for personalized advice on its role in your care. ## Who Qualifies for Assistance? Patient assistance programs (PAPs) for Imfinzi target those facing financial hardship due to high drug costs, especially for serious conditions like cancer. While specific manufacturer programs for AstraZeneca's Imfinzi (the maker) have varying eligibility, third-party services like Simplefill help uninsured or underinsured patients regardless of strict income cutoffs.[1] Qualification often hinges on: - U.S. residency and valid prescription. - Demonstrated financial need (e.g., trouble affording meds despite insurance). - Cancer diagnosis matching Imfinzi's FDA-approved uses. Simplefill does not impose rigid income thresholds; they assess your situation holistically during a quick interview.[1] Medicare patients or those with commercial insurance may still qualify if facing high copays or gaps. ## Income Eligibility Breakdown Many PAPs use Federal Poverty Level (FPL) guidelines, typically 400-500% of FPL, but Imfinzi-specific details via Simplefill focus on individual need rather than fixed limits. Here's a general table for common cancer drug PAPs (adjusted for 2026; check current HHS.gov for exact FPL): | Household Size | 400% FPL Example | 500% FPL Example | Notes | |----------------|-------------------|-------------------|-------| | Individual | $60,240 | $75,300 | Annual income; Simplefill flexible [1] | | Couple | $81,760 | $102,200 | Includes spouse's income | | Family of 3 | $103,280 | $129,100 | Adds ~$21,520 per extra member | | Family of 4 | $124,800 | $156,000 | Varies by program; no strict cap via Simplefill [1] | **Notes:** These are illustrative; Simplefill enrolls based on your profile, not just income. Provide proof like tax returns if requested.[1] ## Insurance Requirements Most PAPs, including those accessed via Simplefill, require patients to be uninsured, underinsured, or have Medicare Part D with coverage gaps. Commercial insurance is often accepted if copays exceed affordability. Medicare patients may qualify for Extra Help or PAPs bridging deductibles. Simplefill handles insurance verification during enrollment.[1] Do not cancel insurance to apply—programs prioritize those exhausting other options first. ## Step-by-Step Application Process 1. **Contact Simplefill:** Apply online or call 1-877-386-0206. This starts your membership—no cost to join.[1] 2. **Phone Interview:** A patient advocate calls within 24 hours for a brief chat on your finances, insurance, diagnosis, and meds.[1] 3. **Profile Creation:** They build your profile to match Imfinzi PAPs. 4. **Paperwork Handling:** Simplefill completes and submits applications for you—no forms needed from you beyond interview info.[1] 5. **Approval Tracking:** They monitor and notify you of approvals. 6. **Ongoing Support:** Once enrolled, they manage refills and updates if your treatment changes.[1] The process is patient-friendly, minimizing your burden during cancer treatment. ## Timeline and Delivery Expect a call within 24 hours of applying. Assistance enrollment varies: 1-4 weeks typical for PAPs, faster via Simplefill's matching. Medication delivers to your doctor's office or pharmacy for infusion—no home shipping. Simplefill ensures continuous supply.[1] ## Alternatives if Denied or Additional Options If denied: - Appeal with updated financials. - Try manufacturer co-pay cards (AstraZeneca offers for commercially insured). - State programs, 340B clinics, or nonprofits like PAN Foundation. - Simplefill re-matches to other PAPs and helps with generics/biosimilars (none currently for Imfinzi).[1] - Explore clinical trials via Cancer.gov. No biosimilar alternatives listed for Imfinzi as of 2026.[1] ## Disclaimer This guide provides general info based on available sources like Simplefill as of March 2026. Eligibility, terms, and availability change—verify directly with programs. Not medical/financial advice; consult your doctor, pharmacist, or advisor. Simplefill is a service, not the manufacturer PAP.[1]

Program information last verified: March 25, 2026